(Press-News.org) Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory conditions. A critical factor, however, is whether the active substances actually kill the pathogens in the body. Researchers at the University of Basel have presented a new method for measuring how effectively antibiotics kill bacteria.
Antibiotic-resistant bacteria are one of the biggest health problems of our time. Due to mutations, bacteria are increasingly resisting the effects of common drugs, making these infections increasingly difficult to treat.
But even without resistance, bacteria are sometimes able to withstand antibiotics, especially if the bacteria are in a dormant state. Although they do not reproduce when in this state, they are not killed by the antibiotics either. This allows the bacteria to wake up and start growing again at a later time, for example after antibiotic therapy has been stopped. Particularly in the case of tuberculosis and other complex infections, which take many months to treat, selecting drugs that kill the bacteria and completely sterilize the infection is crucial.
Previous laboratory tests mainly reported whether a drug stopped bacteria from growing – not whether the bacteria actually died. Researchers led by Dr. Lucas Boeck from the Department of Biomedicine at the University of Basel and University Hospital Basel have developed a new method to better predict treatment success. They have described this new method in the scientific journal Nature Microbiology.
Filming the fate of individual bacteria
The method, which the researchers call “antimicrobial single-cell testing,” is based on microscopic imaging of millions of individual bacteria under thousands of different conditions. “We use it to film each individual bacterium over several days and observe whether and how quickly a drug actually kills it,” explains Lucas Boeck. This makes it possible to measure precisely what proportion of the bacterial population is eliminated by the treatment and how efficiently.
To demonstrate their method, the research team tested 65 combination therapies on the tuberculosis pathogen Mycobacterium tuberculosis. The researchers also tested the method on bacterial samples from 400 patients with a different complex lung infection triggered by Mycobacterium abscessus, which is related to the tuberculosis pathogen.
Differences were observed firstly between different therapies and secondly between different bacterial strains in different patients. Experts call the latter antibiotic tolerance. Subsequent analyses revealed that certain genetic characteristics are responsible for how well the bacteria can “sit out” the antibiotic treatment.
“The better bacteria tolerate an antibiotic, the lower the chances of therapeutic success are for the patients,” says Lucas Boeck, summarizing the results. Compared with data from clinical studies and animal models, the results of antimicrobial single-cell testing provided a very good reflection of how well the different therapeutic agents eradicate infections.
Benefits for patients and drug development
The new method has so far been used as a research tool, but it could also be used in clinics and industry in the future. It could one day be beneficial both for patients and for drug development in a number of ways, explains Lucas Boeck. “Our test method allows us to tailor antibiotic therapies specifically to the bacterial strains in individual patients.” He adds that a better understanding of the underlying genetics could one day enable even simpler and quicker antibiotic tolerance tests to be performed and could also help improve estimates of the efficacy of new drugs during their development.
“Last but not least, the data can help researchers to better understand the survival strategies of pathogens and thus lay the foundation for new, more effective therapeutic approaches,” says Boeck.
END
New test shows which antibiotics actually work
2026-01-09
ELSE PRESS RELEASES FROM THIS DATE:
Most Alzheimer’s cases linked to variants in a single gene
2026-01-09
Potentially more than 90% of Alzheimer’s disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers.
The scientists also found that close to half of all dementia cases would probably not arise without the gene’s influence.
The researchers say that the findings, published today in npj Dementia, highlight this gene (and the protein it produces) as a powerful yet under-recognised target for drug development, which could have the scope to prevent or treat a large proportion of all dementia.
The APOE gene has long been implicated in Alzheimer’s disease. There are three common ...
Finding the genome's blind spot
2026-01-09
EMBARGOED UNTIL 9 January 2026, 11 AM CET, 5 AM ET
Basel, 9 January 2026 – Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with night blindness in youth and progresses to tunnel vision as daylight-sensing photoreceptor cells in the retina gradually die, potentially leading to blindness over time. Although more than a hundred genes have been linked to RP, the genetic cause remains undiagnosed in ~30-40% of patients, even after extensive DNA testing. For many families, this ...
The secret room a giant virus creates inside its host amoeba
2026-01-09
Kyoto, Japan -- A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency partially depends on the usage of a codon, or sequence of three nucleotides, that matches the cellular pool of tRNA, key molecules in translation. Using rare codons that are poorly supported by the cellular tRNA pool tends to induce ribosome pausing and mRNA instability, often weakening the virus.
Yet many eukaryotic viruses use a codon pattern that deviates from their host's while still relying on the host's translation mechanism. Theoretically this mismatch should hinder viral ...
World’s vast plant knowledge not being fully exploited to tackle biodiversity and climate challenges, warn researchers
2026-01-09
An international group of researchers says that biodiversity conservation and scientific research are not benefiting from the vast knowledge about the world’s plants held by botanic gardens, because of fragmented data systems and a lack of standardisation.
In a new report published today in the journal Nature Plants, researchers based at more than 50 botanic gardens and living plant collections warn that a patchwork of incompatible, or even absent, data systems is undermining global science and conservation at a critical moment.
They call for a unified and equitable global data ...
New study explains the link between long-term diabetes and vascular damage
2026-01-09
The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood cells may be an important explanation, and identifies a specific molecule as a possible biomarker.
People with type 2 diabetes are at increased risk of heart attack and stroke, and the risk increases the longer they have lived with the disease. Previous research has shown that red blood cells can affect blood vessel function in diabetes. Now, a new study shows that the duration of the disease plays a decisive ...
Ocean temperatures reached another record high in 2025
2026-01-09
A new international analysis published in Advances in Atmospheric Sciences on 9 January finds that the Earth’s ocean stored more heat in 2025 than in any year since modern measurements began. The 2025 heat increase was 23 Zetta Joules (23,000,000,000,000,000,000,000 Joules of energy), which is equivalent to ~37 years of global primary energy consumption at the 2023 level (~620 Exa Joules per year). The finding is the result of a major international collaboration, involving more than 50 scientists from 31 research ...
Dynamically reconfigurable topological routing in nonlinear photonic systems
2026-01-09
Topological photonics has emerged as a powerful paradigm for achieving robust light transport that is immune to imperfections, disorder, and structural defects. By harnessing principles from condensed matter physics, topological photonic systems support edge modes that guide light along boundaries without backscattering — a feature that has significant implications for resilient optical communication and information processing. However, most demonstrations of topological photonics have been confined to linear and static settings, where the transport pathways are fixed once the device is fabricated. This rigidity presents a major limitation for practical ...
Crystallographic engineering enables fast low‑temperature ion transport of TiNb2O7 for cold‑region lithium‑ion batteries
2026-01-09
As fast-charging lithium-ion batteries race toward sub-zero markets, the anode bottleneck—graphite plating risk and Li4Ti5O12 capacity ceiling—intensifies. Now, researchers from Harbin Institute of Technology, led by Prof. Yan Zhang and Prof. Shuaifeng Lou, unveil an Sb/Nb co-doped TiNb2O7 (TNO) anode that unlocks 140 mAh g-1 at 20 C and 500 stable cycles at −30 °C. Published in Nano-Micro Letters, the work delivers a practical pouch cell delivering 1.14 Ah at 17 C with 93.8 % retention ...
Ultrafast sulfur redox dynamics enabled by a PPy@N‑TiO2 Z‑scheme heterojunction photoelectrode for photo‑assisted lithium–sulfur batteries
2026-01-09
While lithium–sulfur batteries (LSBs) promise 2600 Wh kg⁻¹, the sluggish liquid-solid conversion of polysulfides keeps practical capacities far below theory. Now, researchers at Northwestern Polytechnical University, led by Prof. Yibo He, report a free-standing PPy@N-TiO2/Carbon-Cloth photocathode that harvests sunlight to co-drive sulfur redox, delivering 1 653 mAh g-1 (98.7 % of theory) and 333 mAh g-1 after 5 h of pure photo-charging. Published in Nano-Micro Letters, the work realizes dual-mode energy harvesting in a single cell.
Why Photo-Assisted Strategy Matters
Polysulfide ...
Optimized biochar use could cut China’s cropland nitrous oxide emissions by up to half
2026-01-09
Agricultural soils are one of the world’s largest sources of nitrous oxide, a greenhouse gas nearly 300 times more powerful than carbon dioxide over a century. New research suggests that a common agricultural byproduct may offer a powerful and practical solution. A study published in Biochar shows that straw-derived biochar, when applied using region-specific strategies, could reduce nitrous oxide emissions from China’s croplands by as much as 50 percent.
Nitrous oxide is primarily released from soils treated with nitrogen fertilizers. While biochar, a carbon-rich material produced by heating crop residues under low oxygen conditions, has long been ...